Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.4761
-0.0020 (-0.42%)
At close: Jun 3, 2025, 4:00 PM
0.4930
+0.0169 (3.55%)
After-hours: Jun 3, 2025, 6:20 PM EDT
Talphera Employees
Talphera had 13 employees as of December 31, 2024. The number of employees decreased by 2 or -13.33% compared to the previous year.
Employees
13
Change (1Y)
-2
Growth (1Y)
-13.33%
Revenue / Employee
$2,077
Profits / Employee
-$895,615
Market Cap
9.76M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
TLPH News
- 20 days ago - Talphera, Inc. (TLPH) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 20 days ago - Talphera Announces First Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 27 days ago - Talphera to Host First Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, May 14, 2025 - PRNewsWire
- 2 months ago - Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 2 months ago - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million - PRNewsWire
- 2 months ago - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 - PRNewsWire
- 5 months ago - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - PRNewsWire